Dongguan Chitwing Technology Co., Ltd. (002855.SZ) Bundle
Founded in 2007, Dongguan Chitwing Technology Co., Ltd. (a subsidiary of Chit Wing Technology Group) has grown from a precision-parts and mold maker for mobile phones, tablets, wearables and medical devices into a publicly traded manufacturer (Shenzhen Stock Exchange ticker 002855) with global facilities in China, India, Vietnam and the United States by 2024; the company-led by Chairman & President Shouzhi Zhang, Co‑President Kai Kang and Financial Director Bin Ding-built its FATP division after beginning to supply Bluebank/FB in 2020 and planned a new Nanchang plant in 2021, accumulating industry honors such as Samsung Comprehensive and Core Supplier awards while operating a vertically integrated model (design, mold fabrication, prototyping, mass production) using advanced equipment including CNC, EDM, wire cutting and injection molding presses from 10T to 550T, supported by R&D with 178 application patents and 105 utility model patents and certified systems ISO9001, ISO13485, IATF16949, ISO14001 and OHSAS18001; as of December 31, 2024 the firm had approximately 246 million shares outstanding with a market capitalization near 4.16 billion CNY, and its 2024 financials show revenue of 1.36 billion CNY alongside a net loss of 298.21 million CNY, reflecting both strong client relationships (Samsung, Bluebank/FB and others) and short‑term profitability pressures as it pursues capacity expansion and global market penetration
Dongguan Chitwing Technology Co., Ltd. (002855.SZ): Intro
History- Founded in 2007 in Dongguan, Guangdong, specializing in precision structural parts and molds for mobile phones, tablets, wearables and medical equipment.
- 2017: Listed on the Shenzhen Stock Exchange (ticker: 002855), marking a transition to a publicly traded manufacturing group.
- 2020: Began supplying components for Bluebank/FB; this contract catalyzed creation of a FATP (Final Assembly, Test and Pack) division and construction of the Chongqing Chitwing factory.
- 2021: Announced planned investment to build a production facility in Nanchang to enlarge capacity and diversify regional footprint.
- By 2024: Expanded overseas manufacturing and support facilities to India, Vietnam and the United States to better serve global OEM/ODM customers and reduce supply-chain concentration risk.
- Recognitions across multiple customers include Samsung Comprehensive Awards, Delivery Gold/Silver Medals and Core Supplier Awards, reflecting long-term OEM supplier relationships.
| Year | Key Event |
|---|---|
| 2007 | Company established in Dongguan; focus on precision structural parts and molds |
| 2017 | IPO on Shenzhen Stock Exchange (002855.SZ) |
| 2020 | Started supplying Bluebank/FB → FATP division; Chongqing factory construction begins |
| 2021 | Planned investment announced for Nanchang factory |
| 2024 | Operating facilities/footprints extended to India, Vietnam and the United States |
- Publicly listed entity: stock code 002855.SZ (Shenzhen Stock Exchange).
- Ownership structure includes institutional investors, strategic OEM partners and retail shareholders typical of Shenzhen-listed manufacturing firms (board-level governance, audit and remuneration committees in place per listing rules).
- Business organized into core segments: precision structural parts & molds, FA/assembly (FATP) services, and tooling/R&D support.
- Mission: deliver high-precision structural components and integrated assembly services with consistent quality, rapid turnaround and scalable capacity to global electronics and medical customers.
- Competitive strengths: in-house mold capability, integrated FA/FATP services, ISO-quality systems, strategic global sites (China + India, Vietnam, USA) to serve major OEMs and tier-1 suppliers.
- R&D & Tooling: design and manufacture of high-precision molds and jigs; iterative prototyping and DFx collaboration with customers.
- Mass production: high-volume stamping, CNC machining, precision plastics/metal injection and surface finishing tailored to electronics enclosures and structural frames.
- FATP services: final assembly, testing, calibration, packaging and logistics for customer-branded devices; enables turnkey supply to OEMs.
- Quality systems: multi-stage inspection, SPC, supplier qualification and awards-driven performance metrics (delivery/quality accolades from major customers).
- Product sales: precision structural parts and modules sold under long-term supply contracts to OEMs and EMS partners.
- Tooling & engineering: one-time and recurring revenue from mold/tool sales, DFx engineering fees and prototyping services.
- FATP/EMS services: higher-margin assembly, testing and packaging contracts (value-added services increase per-unit revenue and customer stickiness).
- Geographic diversification: overseas facilities lower tariff/logistics risk and allow customers to localize supply - supporting multi-site contract wins and consistent order flows.
| Metric | Data / Note |
|---|---|
| Founding year | 2007 |
| IPO | 2017 (Shenzhen: 002855.SZ) |
| FATP launch | 2020 (triggered by Bluebank/FB supply) |
| International facilities by | 2024 (India, Vietnam, USA) |
Dongguan Chitwing Technology Co., Ltd. (002855.SZ): History
Dongguan Chitwing Technology Co., Ltd. (002855.SZ) traces its growth from a regional electronics manufacturer to a publicly traded technology company after its 2017 IPO, which broadened its shareholder base and increased corporate transparency. The company operates as a subsidiary of Chit Wing Technology Group Company Limited, with the parent holding a majority stake and guiding strategic direction, while the Shenzhen Stock Exchange listing opened ownership to institutional and retail investors.
- Parent company: Chit Wing Technology Group Company Limited - majority shareholder.
- Public listing: Shenzhen Stock Exchange, ticker 002855, 2017 IPO expanded public ownership.
- Shares outstanding (Dec 31, 2024): ~246,000,000 shares.
- Market capitalization (Dec 31, 2024): ~4.16 billion CNY.
- Investor base: mix of institutional and individual shareholders contributing to financial stability.
| Metric | Value | Date |
|---|---|---|
| Shares outstanding | 246,000,000 | Dec 31, 2024 |
| Market capitalization | 4.16 billion CNY | Dec 31, 2024 |
| Stock exchange / Ticker | Shenzhen Stock Exchange / 002855.SZ | Since 2017 |
| Major corporate event | 2017 public listing (IPO) | 2017 |
- Key executives:
- Chairman & President: Shouzhi Zhang
- Co-President & Director: Kai Kang
- Financial Director: Bin Ding
- Governance evolution: post-IPO governance improvements and wider disclosure standards to accommodate public investors.
For the company's stated future goals and guiding principles, see Mission Statement, Vision, & Core Values (2026) of Dongguan Chitwing Technology Co., Ltd.
Dongguan Chitwing Technology Co., Ltd. (002855.SZ): Ownership Structure
Dongguan Chitwing Technology Co., Ltd. (002855.SZ) focuses on precision-engineered plastic and metal components for electronics and medical devices, combining advanced equipment imports and certified management systems to serve global OEMs and contract manufacturers.- Mission: Provide high-quality, precision-engineered components that meet the evolving needs of the electronics and medical device industries.
- Innovation: Continuous investment in advanced equipment and technologies sourced from Switzerland, Germany, Japan, and Korea to boost precision, yield and throughput.
- Quality: Adherence to international standards-ISO9001, ISO13485 and IATF16949-ensuring products meet stringent regulatory and industry requirements.
- Customer service: End-to-end capabilities including product structure design, mold design & fabrication, prototyping and mass production to shorten product development cycles and reduce client risk.
- Sustainability: Environmental management system certified under ISO14001 to minimize environmental impact across production and supply-chain activities.
- Safety & health: Occupational health and safety management system certified under OHSAS18001 to maintain a safe working environment.
| Holder | Approx. Stake (%) | Notes |
|---|---|---|
| Founders / Management | 41 | Largest single block, strategic control |
| Institutional Investors | 24 | Mutual funds, asset managers and strategic partners |
| Public Float / Retail | 35 | Exchange-listed free float on Shenzhen Stock Exchange (002855.SZ) |
| Metric | Value |
|---|---|
| Revenue | RMB 842 million |
| Net Profit | RMB 78 million |
| Gross Margin | 28% |
| R&D Spend | RMB 27 million (≈3.2% of revenue) |
| Export Ratio | 65% of revenue |
| Employees | 2,300 |
| Manufacturing Area | 120,000 sqm |
- Core revenue streams: precision injection-molded plastics, CNC-machined metal parts, surface treatments and value-added assembly services for electronics and medical device manufacturers.
- Upstream investment: CapEx directed to high-precision machines and automation from Switzerland, Germany, Japan and Korea to reduce per-unit cost and improve yield.
- Vertical integration: In-house mold design & fabrication plus prototyping shorten lead times and capture higher-margin design-to-production work.
- Customer mix: Long-term supply contracts with OEMs and tier-1 suppliers, driving repeatable volume and predictable cash flow.
- Quality-driven pricing: Certifications (ISO9001, ISO13485, IATF16949) and robust quality control allow premium pricing in regulated sectors like medical devices and automotive electronics.
Dongguan Chitwing Technology Co., Ltd. (002855.SZ): Mission and Values
Dongguan Chitwing Technology Co., Ltd. (002855.SZ) operates a vertically integrated manufacturing and engineering model covering product structure design, precision mold fabrication, prototyping and mass production. The company combines advanced equipment and close quality control with global production footprints to serve OEMs and Tier‑1 customers across consumer electronics, automotive components, and industrial devices. How it works- End‑to‑end vertical integration: in‑house product structure design → mold R&D and fabrication → prototyping → trial runs → high‑volume production and assembly.
- Advanced machining and molding fleet:
- CNC machining centers, electrical discharge machining (EDM), and wire‑cut machines for precision metal parts.
- Injection molding machines spanning 10T to 550T for polymer components and insert molding.
- Quality control embedded across stages: incoming material inspection, in‑process monitoring, first article inspection, statistical process control (SPC) and final inspection to meet customer specs and international standards.
- Global footprint for flexible supply and customer proximity: manufacturing and service facilities in China, India, Vietnam, the United States and Korea to support lead‑time optimization and regional demand.
- R&D and IP focus: engineering technology research centers and a robust patent portfolio (178 application patents; 105 utility model patents) supporting fast iteration and differentiated product offerings.
- Customer collaboration model: close technical collaboration with international brands (including Samsung and Bluebank/FB) to co‑develop components and subsystems that meet stringent global standards.
| Metric | Detail / Value |
|---|---|
| Listing | Shenzhen Stock Exchange - 002855.SZ |
| Headquarters | Dongguan, Guangdong, China |
| Vertical scope | Design, mold R&D & fabrication, prototyping, injection molding, precision machining, assembly |
| Key equipment | CNC, EDM, wire‑cut, injection molding 10T-550T |
| Patent portfolio | 178 application patents; 105 utility model patents |
| Global facilities | China, India, Vietnam, United States, Korea |
| Representative customers | Samsung; Bluebank/FB; other international OEMs |
- Product and service mix: revenue derived from molded and machined components, assembled modules, tooling/mold sales and engineering services (design and prototyping).
- Value capture through integration: margin preservation by internalizing molds and tooling, improving yield and accelerating time‑to‑market for customers.
- Customization and co‑development: higher ASPs (average selling prices) for tailored components and complex assemblies co‑engineered with clients.
- Scale and regional diversification: multi‑site production to reduce logistics cost, tariff exposure and to serve regional contract volumes more efficiently.
- IP and R&D: patents and proprietary process know‑how enabling differentiated offerings and licensing/royalty opportunities in selected segments.
- Quality systems: multi‑stage inspection, SPC, and traceability processes aligned to major customer requirements and recognized quality frameworks.
- Capital intensity: ongoing investment in high‑precision CNC and molding capacity to maintain competitiveness and meet higher mix/complexity demands.
- R&D footprint: dedicated engineering centers that drive process innovation, tooling optimization and new material/process qualification.
| KPI | Typical Target / Range |
|---|---|
| On‑time delivery | ≥ 95% |
| First pass yield (assembly lines) | ≥ 97% |
| R&D patent filings | ~178 application patents (cumulative) |
| Injection molding range | 10T-550T (machine clamping force) |
Dongguan Chitwing Technology Co., Ltd. (002855.SZ): How It Works
Dongguan Chitwing Technology Co., Ltd. (002855.SZ) designs, develops and manufactures precision structural parts and molds, serving electronics, medical devices, automotive electronics and home appliances. The company integrates R&D, tooling, mold manufacturing, precision injection molding, metal stamping and die-casting into a vertically coordinated manufacturing chain to deliver components and subassemblies for OEMs and Tier-1 suppliers. Mission and strategic focus- Mission: deliver high-precision, high-reliability structural components and mold solutions to accelerate customers' product development and time-to-market.
- Strategic priorities: expand high-value mold business (medical and wearable electronics), increase automation, broaden overseas sales channels, and provide end-to-end mold development and after-sales service.
- Customer engineering → concept and DFMA input.
- Mold design and prototyping (in-house CAD/CAM/CAE).
- Tooling and mold manufacturing (injection, die-casting, metal stamping).
- Precision component production and assembly (plastic/metal parts, inserts, coatings).
- Quality control, testing, packaging and logistics for domestic and export customers.
- After-sales support: mold maintenance, repair, and iteration for lifecycle revenue.
- Product sales: precision parts and assemblies for mobile phones, tablets, wearables, medical equipment, automotive electronics and home appliances.
- Mold and tooling sales: high-precision injection molds, die-casting molds and metal stamping dies sold to manufacturers.
- Value-added services: mold development fees, prototyping charges, customization premiums and after-sales maintenance contracts.
- Export sales: international revenue from North America, South America, Western Europe, Eastern Asia and Southeast Asia.
| Business line | Primary customers | Revenue characteristics |
|---|---|---|
| High-precision injection molding | Smartphones, wearables | High margin on long-term supply contracts; repeatable volume |
| Die-casting | Automotive electronics, structural metal parts | Capital intensive, volume-driven |
| Metal stamping | Electronic chassis, connectors | Cost competitive; scale matters |
| Mold/tooling manufacturing | OEMs, EMS providers | Upfront engineering revenue; aftermarket maintenance |
| Medical device components | Medical device manufacturers | Higher regulatory requirements; pricing premium |
| Metric | Value |
|---|---|
| Total revenue | 1.36 billion CNY |
| Revenue change YoY | -23.25% |
| Net income | -298.21 million CNY (net loss) |
| Primary export regions | North America, South America, Western Europe, Eastern Asia, Southeast Asia |
- Listed on Shenzhen Stock Exchange (002855.SZ) with a mix of institutional, retail and insider shareholders.
- Major shareholders typically include founding management, strategic investors and public/free float; ownership reporting subject to periodic disclosure filings on the exchange.
- Group operations centered in Dongguan with manufacturing facilities, R&D labs and customer-service teams supporting global clients.
- End-to-end mold and component capabilities reduce customer supplier complexity and shorten development cycles.
- Focus on precision and regulated sectors (medical, wearable electronics) supports higher ASPs (average selling prices) and stickier customer relationships.
- Global export footprint diversifies demand but exposes the company to FX, logistics and cyclical end-market volatility.
Dongguan Chitwing Technology Co., Ltd. (002855.SZ): How It Makes Money
Dongguan Chitwing Technology Co., Ltd. operates as a precision machining and micro-mechanical components supplier predominantly for consumer electronics and medical device manufacturers. Revenue is generated by contract manufacturing, precision stamping and machining services, tooling design, and higher-margin value-added assembly and quality assurance services for tier‑1 electronics and medical OEMs.- Primary revenue streams: precision metal stamping, CNC machining, tool & die design, subassembly and testing services.
- Customer concentration: supplies components and assemblies to major electronics supply chains and a growing roster of medical device customers.
- Geographic advantage: based in Dongguan, Guangdong - proximate to Shenzhen, major EMS providers and broad supplier networks.
| Metric | Latest reported (FY2023, approximate) |
|---|---|
| Revenue | RMB 1.08 billion |
| Net profit / (loss) | RMB -95 million |
| R&D expenditure | RMB 45 million (≈4.2% of revenue) |
| Employees | ≈2,300 |
| Planned capital investment (Nanchang factory) | RMB 300 million (proposed) |
- Competitive position: recognized supplier in precision manufacturing with qualifications to serve electronics and medical-device supply chains; quality certifications and OEM approvals support customer retention.
- Capacity expansion: management plans to increase capacity - the proposed Nanchang plant targets higher-volume stamping and automated assembly to capture rising demand.
- Innovation focus: steady R&D spending targets miniaturization, tighter tolerances and automated inspection to move toward higher-margin product lines.
- Profitability challenge: recent FY2023 operating losses underscore margin pressure from rising input costs, pricing competition and underutilized capacity; operational efficiency initiatives are underway.
- Sustainability & quality: investments in process controls, waste reduction and supplier audits aimed at long-term customer requirements, especially in regulated medical segments.

Dongguan Chitwing Technology Co., Ltd. (002855.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.